PDS Biotechnology Corporation
General ticker "PDSB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $53.9M (TTM average)
PDS Biotechnology Corporation does not follow the US Stock Market performance with the rate: -4.4%.
Estimated limits based on current volatility of 4.7%: low 0.79$, high 0.88$
Factors to consider:
- Total employees count: 25 as of 2023
- Top business risk factors: Dependence on key products, Limited operating history, Significant losses, Need for additional capital, Regulatory and compliance
- Current price 15.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.06$, 3.20$]
- 2025-12-31 to 2026-12-31 estimated range: [1.02$, 2.99$]
Financial Metrics affecting the PDSB estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -56.45 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 41.90 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of -0.05 > -0.66
- Negative: negative Net income
Short-term PDSB quotes
Long-term PDSB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $41.67MM | $43.05MM | $36.32MM |
| Operating Income | $-41.67MM | $-43.05MM | $-36.32MM |
| Non-Operating Income | $-0.38MM | $-1.30MM | $-2.16MM |
| Interest Expense | $1.32MM | $4.21MM | $4.67MM |
| R&D Expense | $29.43MM | $27.76MM | $22.57MM |
| Income(Loss) | $-42.05MM | $-44.35MM | $-38.48MM |
| Taxes | $-1.20MM | $-1.41MM | $-0.87MM |
| Profit(Loss)* | $-40.85MM | $-42.94MM | $-37.61MM |
| Stockholders Equity | $44.00MM | $26.13MM | $19.00MM |
| Assets | $77.01MM | $59.39MM | $45.36MM |
| Operating Cash Flow | $-25.71MM | $-33.64MM | $-35.03MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.03MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.03MM |
| Financing Cash Flow | $34.29MM | $16.38MM | $20.19MM |
| Earnings Per Share** | $-1.43 | $-1.39 | $-1.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.